Q: You have written past columns in which you said it is very difficult to qualify for Social Security disability benefits. I ...

Some beneficiaries will receive their final April check this week. Here’s the payment schedule and how to spot fake SSA ...

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to ...

Healthcare workers announced a hunger strike last Thursday until the No More 24 Act (Int. 303) is passed — a last-resort ...

Kyverna Therapeutics has unveiled the full results from its registrational trial of miv-cel in stiff person syndrome (SPS), ...

These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...

A flood of fully registered “cleanskin” NDIS businesses are being listed for sale on sites like Gumtree and Facebook ...

About ENSPRYNG® (satralizumab) ENSPRYNG, which was developed by Chugai, a member of the Roche Group, is a humanised monoclonal antibody that targets interleukin-6 (IL-6) receptor activity. ENSPRYNG ...

Private school leaders in Laredo discussed Texas' voucher system, showing support for expanded education choice. District ...

Iowa lawmakers hit the goal end date for the 2026 legislative session Tuesday, but there are still several issues legislators ...

Wealth Enhancement reports homeowners can convert their home equity into retirement income via downsizing, HELOCs, cash-out ...

Aging parents of children with autism ask the most difficult question: 'What happens when we are gone?' Families are ...